Article
Random forest modelling demonstrates microglial and protein misfolding features to be key phenotypic markers in C9orf72-ALS.
The Journal of pathology - 1 Dec 2022
Rifai Olivia M, Longden James, O'Shaughnessy Judi, Sewell Michael DE, Pate Judith, McDade Karina, Daniels Michael Jd, Abrahams Sharon, Chandran Siddharthan, McColl Barry W, Sibley Christopher R, Gregory Jenna M
Abstract excerpt
Clinical heterogeneity observed across patients with amyotrophic lateral sclerosis (ALS) is a known complicating factor in identifying potential therapeutics, even within cohorts with the same mutation, such as C9orf72 hexanucleotide repeat expansions (HREs). Thus, further understanding of pathways underlying this heterogeneity is essential for appropriate ALS trial stratification and the meaningful assessment of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
